全文获取类型
收费全文 | 112297篇 |
免费 | 10719篇 |
国内免费 | 6096篇 |
专业分类
耳鼻咽喉 | 701篇 |
儿科学 | 3078篇 |
妇产科学 | 1291篇 |
基础医学 | 9903篇 |
口腔科学 | 1218篇 |
临床医学 | 10124篇 |
内科学 | 22105篇 |
皮肤病学 | 908篇 |
神经病学 | 2394篇 |
特种医学 | 5463篇 |
外国民族医学 | 66篇 |
外科学 | 14476篇 |
综合类 | 20217篇 |
现状与发展 | 38篇 |
预防医学 | 3715篇 |
眼科学 | 631篇 |
药学 | 9622篇 |
72篇 | |
中国医学 | 6147篇 |
肿瘤学 | 16943篇 |
出版年
2024年 | 289篇 |
2023年 | 1909篇 |
2022年 | 3533篇 |
2021年 | 4904篇 |
2020年 | 4361篇 |
2019年 | 3822篇 |
2018年 | 3608篇 |
2017年 | 4140篇 |
2016年 | 4849篇 |
2015年 | 4731篇 |
2014年 | 7269篇 |
2013年 | 7262篇 |
2012年 | 6432篇 |
2011年 | 7158篇 |
2010年 | 5668篇 |
2009年 | 5589篇 |
2008年 | 5627篇 |
2007年 | 5881篇 |
2006年 | 5552篇 |
2005年 | 4744篇 |
2004年 | 3960篇 |
2003年 | 3395篇 |
2002年 | 3083篇 |
2001年 | 2800篇 |
2000年 | 2313篇 |
1999年 | 2016篇 |
1998年 | 1809篇 |
1997年 | 1635篇 |
1996年 | 1446篇 |
1995年 | 1277篇 |
1994年 | 1143篇 |
1993年 | 907篇 |
1992年 | 800篇 |
1991年 | 658篇 |
1990年 | 559篇 |
1989年 | 492篇 |
1988年 | 472篇 |
1987年 | 388篇 |
1986年 | 318篇 |
1985年 | 381篇 |
1984年 | 340篇 |
1983年 | 215篇 |
1982年 | 274篇 |
1981年 | 228篇 |
1980年 | 176篇 |
1979年 | 167篇 |
1978年 | 140篇 |
1977年 | 109篇 |
1976年 | 120篇 |
1975年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
171.
J.P. Brouillet B. Hanslick T. Maudelonde M.T. Pivat J. Grenier F. Blanc H. Rochefort 《Clinical biochemistry》1991,24(6):491-496
Using a sandwich enzyme-linked immunoassay, plasma total cathepsin D concentration was assayed in 40 breast cancer patients and 84 patients with various liver diseases and compared to that of 52 normal subjects. There were no significant variations found in breast cancer patients related to tumor size, node invasiveness or metastases. In normal women, cathepsin D levels were slightly but not significantly increased in the luteal phase and in pregnancy. By contrast, plasma cathepsin D concentration was significantly increased in 70-75% of patients with liver disease (cirrhosis, hepatocarcinoma, hepatitis), but not in those with liver steatosis. Cathepsin D was independent of most of the plasma hepatic function tests and was correlated with alpha-fetoprotein in cirrhosis and with alpha-fucosidase in primary hepatocellular carcinoma. We conclude that plasma cathepsin D is not a useful marker in breast cancer. However, since the cellular level of this protease is associated with risk of metastasis in breast cancer, clinical follow-up will be required to test whether high cathepsin D plasma concentration has any prognostic value in liver cirrhosis and primary hepatocarcinoma. 相似文献
172.
青年人原发性肝癌的治疗与预后分析 总被引:2,自引:0,他引:2
目的:探讨青年人原发性肝癌手术切除率低及术后复发率较高的原因.方法:将1985年1月~2000年1月收治的原发性肝癌173例患者分为青年组(≤35岁)83例和中老年组(≥36岁)90例,对其临床资料、手术切除率、术后复发率及生存率等进行比较分析.结果:青年组原发性肝癌手术切除率、术后1年复发率分别为26.51%(22/83)和68.18%(15/22),术后1、3、5年生存率分别为59.09%(13/22)、22.73%(5/22)和9.09%(2/22).中老年组原发性肝癌手术切除率、术后1年复发率分别为53.33%(48/90)和37.50%(18/48),术后1、3、5年生存率分别为81.25%(39/48)、47.92%(23/48)和39.58%(19/48).青年组各项生存率指标均较中老年组低(P<0.01).结论:青年组原发性肝癌具有肿瘤生长迅速、侵袭力强、门静脉癌栓发生率高、多表现为巨块型及弥漫型等特点,导致手术切除率较低及术后复发率较高. 相似文献
173.
目的:观察密盖息(鲑鱼降钙素)的治疗骨转移瘤疼痛和血清钙的临床疗效。方法:单用组用密盖息100IU,肌肉注射,每日2次,共7d。联合化疗组化疗后加密盖息100IU肌肉注射,每日2次,每次7d。治疗结束进行疗效评价。结果:单用组骨痛完全缓解66.7%(12/18)。联合化疗组骨痛完全缓解率87.1%(27/31)。单用组血钙降至正常,占77.8%(14/18),联合化疗组血钙完全降至正常占100%(31/31)。副作用是暂时性的心动过速、皮肤潮红、头晕、恶心呕吐,无需特殊处理,自行缓解。结论:密盖息治疗骨转移瘤有止痛、降低血钙作用良好,副作用小,可以在临床上安全使用。 相似文献
174.
Kimberly A. Varker Edward W. Martin Dori Klemanski Bryan Palmer Manisha H. Shah Mark Bloomston 《Journal of gastrointestinal surgery》2007,11(12):1680-1685
Background
Transarterial chemoemobolization (TACE) is commonly used to treat metastatic carcinoid tumors; however, the management of
progressive disease is less clear. We sought to determine if patients with disease progression after TACE would benefit from
repeat TACE.
Methods
The records of 27 patients undergoing repeat TACE for radiologic or symptomatic progression after TACE for metastatic carcinoid
were reviewed and compared to 122 undergoing first TACE. Overall and progression-free survivals were estimated by the Kaplan–Meier
method.
Results
Mean disease-free interval after first TACE was 11.8 months. Radiologic response was observed in 61% compared to 82% after
first TACE (p = 0.058); hormone response in 64% compared to 80% (p = 0.159); and symptomatic response in 77% compared to 92% (p = 0.053). The complication rate after repeat TACE was lower than after first TACE (p = 0.03). Median overall survival was similar after repeat (28.1 months) and first TACE (33.3 months) (p = 0.53). Progression-free survival was shorter after repeat TACE but not significantly so. No factor examined could predict
survival after repeat TACE.
Conclusion
Repeat TACE for patients with hepatic carcinoid metastases failing first TACE or having evidence of disease progression is
safe and offers a viable treatment option.
Presented at the 48th Annual Meeting of The Society for Surgery of the Alimentary Tract, Washington, DC, May, 2007. 相似文献
175.
目的探讨经乙状窦后入路显微手术治疗桥小脑角占位性病变引起的继发性三叉神经痛的疗效。方法回顾分析我院2000年10月~2006年7月37例继发性三叉神经痛的临床资料,其中胆脂瘤18例,脑膜瘤8例,听神经瘤6例,三叉神经鞘瘤5例,均经乙状窦后入路显微手术切除肿瘤。结果肿瘤全切23例,次全切除10例,部分切除4例。35例疼痛症状消失(32例立即消失,3例术后2个月消失),随访3个月~5年无复发;2例无效。发生暂时性面瘫6例,面部麻木6例,无颅内感染及脑脊液漏。结论经乙状窦后入路显微手术是治疗继发性三叉神经痛安全有效的方法。 相似文献
176.
Conjugated linoleic acid (CLA) is a unique lipid that elicits dramatic reductions in adiposity in several animal models when included at < or = 1% of the diet. Despite a flurry of investigations, the precise mechanisms by which conjugated linoleic acid elicits its dramatic effects in adipose tissue and liver are still largely unknown. In vivo and in vitro analyses of physiological modifications imparted by conjugated linoleic acid on protein and gene expression suggest that conjugated linoleic acid exerts its de-lipidating effects by modulating energy expenditure, apoptosis, fatty acid oxidation, lipolysis, stromal vascular cell differentiation and lipogenesis. The purpose of this review shall be to examine the recent advances and insights into conjugated linoleic acid's effects on obesity and lipid metabolism, specifically focused on changes in gene expression and physiology of liver and adipose tissue. 相似文献
177.
178.
李剑锋 《世界中西医结合杂志》2008,3(3):165-166
肠易激综合征(IBS)是一组持续存在或反复发作的临床症候群,主要症状有腹痛、腹胀、排便习惯改变和大便性状异常、黏液便等,经检查排除可引起这些症状的器质性疾病。临床分为肝木乘脾型腹泻、脾胃虚弱型腹泻、脾肾阳虚型腹泻、肝郁脾虚型便秘四型,根据临床辨证分别施以不同治法,不同方药治疗,有显著疗效。同时,教育患者平时养成良好的饮食卫生习惯,不饮生水,不食生冷瓜果,忌食辛辣、油腻、肥厚之品,保持心情舒畅,怡情悦志,注意保暖,可加强疗效,防止复发。 相似文献
179.
Ian F. Dunn Pankaj K. Agarwalla Alexander M. Papanastassiou William E. Butler Edward R. Smith 《Child's nervous system》2007,23(10):1191-1194
Objective Approximately 10% of patients with neurofibromatosis I (NFI) patients will have central nervous system (CNS) tumors. The most
common of these are hypothalamic–optic gliomas, followed by brainstem and cerebellar pilocytic astrocytomas. While isolated
pilocytic astrocytomas in NFI are well described, the appearance of multiple pilocytic astrocytomas in an individual patient
is less common. The most frequent combination in NFI patients with more than one pilocytic astrocytoma is optic tract/hypothalamic
and brainstem. Other combinations are exceedingly rare; multiple pilocytic astrocytomas have only been reported once in the
cerebral hemispheres in a patient with NFI. This report presents the first documented case, to our knowledge, of multiple
pilocytic astrocytomas in the cerebellum of a patient with NF1.
Methods Case report.
Conclusion The finding of multiple cerebellar pilocytic astrocytomas in a patient with NF1 is important because it expands the spectrum
of presentations for patients with NF1 and also highlights specific diagnostic and therapeutic challenges faced by the treating
physicians. The genetic and molecular basis of NF1 is reviewed. Strategies of diagnosis and treatment outlined here are relevant
to both patients with NF1 and all patients with multiple posterior fossa tumors. 相似文献
180.